J96.11
Conditions
Interventions
Group 1: •Mobile arterial blood gas analysis (ABG): Outpatient measurement of pH, pCO2, pO2, HCO3?, and other parameters to assess the respiratory status.
•Telemonitoring (recording of ventilation par
Sponsors
Kliniken der Stadt Köln, Abteilung für Pulmologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with established non-invasive ventilation (NIV) therapy for at least three months due to type 2 respiratory failure Presence of capacity to consent as well as signed data protection and informed consent documents
Exclusion criteria
Exclusion criteria: Age under 18 years Presence of deafness Lack of capacity to consent without legal guardianship
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in quality of life based on the SRI score (comparison t0 vs. t12); t0 = baseline visit; t12 = final visit after 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| •Descriptive analysis of demographic characteristics and care situation •Assessment of ventilation quality •Recording of hospitalization rate •Evaluation of therapy adherence (compliance) •Determination of exacerbation rate (moderate and severe) over time (t0 vs. t12) •Assessment of patient satisfaction using standardized questionnaires | — |
Countries
Germany
Contacts
Public ContactSarah Bettina Stanzel
Kliniken der Stadt Köln, Abteilung für Pulmologie
Outcome results
None listed